Testosterone Lawsuit Lawyer –
Lawyers at Matthews & Associates are handling Testosterone Lawsuit claims for men who have suffered heart attack, stroke, deep vein thrombosis, DVT, blood clots or pulmonary embolism after taking prescription testosterone products. Low-T or low testosterone supplements include Androderm, Androgel, Axiron, Bio-T-Gel, Delatestryl, Depo Testosterone, Fortesta, Striant, Testim, Testopel. These FDA-approved products are applied through topical gel, transdermal patch, buccal system (gum), and/or injection.
Testosterone raises Heart Attack, Stroke Risks
A study published in the Nov. 2013 Journal of the American Medical Association (JAMA) found testosterone therapy increases one’s risk of heart attack, stroke, and death. Nine thousand (9,000) male veterans participated in the study. The mean age of the men was 60. All had survived coronary angiography and all had been determined to have low testosterone. About 15% of the men began testosterone therapy. Twenty six (26) percent suffered a heart attack or stroke or died from another cause in a roughly three-year span. In comparing the 26% to the group not taking testosterone therapy, researchers concluded that men on such testosterone medications risk a 30% higher chance of serious, potentially deadly heart issues.
Increase Testosterone Naturally in Minutes?
FDA Safety Alert
Based in part on the November JAMA publication, the FDA announced on Jan. 31, 2014 that it is evaluating the risk of stroke, heart attack and death from testosterone products. In a safety alert the agency said it would reassess the safety of testosterone therapy products. The FDA action was additionally prompted by a study published last month in PLOS ONE regarding testosterone and heart attacks. It showed testosterone therapy for men over 65 doubled their risk of heart attack and tripled the risk of cardio events for men under 65 with pre-existing heart disease.
FDA Approval is Limited
Testosterone products are FDA-approved only for men with low testosterone levels who also have an associated medical condition. These conditions include a failure of testicles to produce testosterone, whether for genetic reasons, chemotherapy poisoning, or some other malady. Brain structure problems can also affect testosterone levels. The hypothalamus or pituitary control production of testosterone in the testicles. The FDA has not approved any of the testosterone products for men with low testosterone who do not have an associated medical condition.
Aggressive Marketing Blitz
Men across the U.S. are being urged by aggressive marketing to seek treatment not only for symptoms of “Low T,” but also low energy, sagging muscles, decreased libido, mood changes, emotional issues, etc. The marketing has worked. Prescriptions for low testosterone (or Low-T) therapy have more than doubled since 2006. In 2011, 5.3 million testosterone prescriptions were written in the U.S. Estimates say 13.8 million American men now experience the effects of lowered testosterone levels.
These products are used by nearly 4% of men in their 60s, but only about half those men actually have hypogonadism, a diminished functional activity of the gonads. Nearly 25% of patients never even had their testosterone levels checked before beginning the therapy.
Side effects and Risks of TRT
Other side effects include enlarged prostate or breasts, blood clots, sleep apnea, liver disease, high cholesterol, blocked arteries. Injuries can occur within 90 days of testosterone therapy.
A Doctor explains Low Testosterone is not so simple
Low T Products – Brand Manufacturers
Androgel – AbbVie Pharmaceuticals
Androderm – Actavis, Inc.
Axiron – Ely Lilly & Company
Bio-T-Gel – Biosante/Teva Pharmaceutical Industries
Delatestryl – Sandoz Canada Inc.
Depo Testosterone – Pfizer Inc.
Foresta – Endo Pharmaceuticals
Striant – Actient Pharmaceuticals
Testim – Auxilium Pharmaceuticals
Testopel – Auxilium Pharmaceuticals
Low T Products – Generic Manufacturers
Testosterone Cypionate – Paddock Laboratories, Inc. (Perrigo Co.)
Testosterone Cypionate – Watson Pharmaceuticals (now Actavis)